The coronary artery bypass graft (CABG) market is a critical segment of the cardiovascular devices industry, providing life-saving surgical solutions for patients with coronary artery disease, myocardial ischemia, and other cardiovascular conditions. CABG surgery restores blood flow to the heart by bypassing blocked coronary arteries using grafts from the patient's own vessels or synthetic materials. With rising prevalence of cardiovascular diseases, aging population, and technological advancements in surgical techniques, this market is experiencing steady growth.

The market was valued at USD 13.31 billion in 2024, about USD 14.4 billion in 2025, and is projected to reach roughly USD 31.73 billion by 2035, growing at a CAGR of approximately 8.22%. Growth is driven by the growing geriatric population, rising healthcare expenditure, awareness and education initiatives, increasing prevalence of cardiovascular diseases, and technological advancements in surgical techniques.

By application, coronary artery disease holds the largest share, driven by its prevalence and high rates of associated surgical interventions. Myocardial ischemia is the fastest-growing segment, reflecting increasing awareness and diagnosis rates.

By surgical technique, traditional CABG leads due to its reliability and established efficacy. Robotic-assisted CABG is the fastest-growing segment, driven by technological advancements and increasing preference for less invasive procedures.

By type of graft, saphenous vein graft holds the largest share due to its widespread usage and established effectiveness. Internal mammary artery graft is the fastest-growing segment, driven by advancements in surgical techniques and increase in minimally invasive procedures.

By end-user, hospitals lead due to their extensive utilization of advanced medical technologies and consistent requirement for advanced sterilization methods. Cardiology clinics and research institutes also contribute significantly.

Regionally, North America leads with 50.04% market share, supported by advanced healthcare infrastructure, increasing prevalence of cardiovascular diseases, and strong focus on innovative surgical techniques. Europe follows with steady expansion, while Asia-Pacific is the fastest-growing region, driven by rising disposable incomes, increasing prevalence of heart diseases, and improvements in healthcare infrastructure.

Key players include Medtronic, Boston Scientific, Abbott Laboratories, Johnson & Johnson, B. Braun Melsungen AG, Terumo Corporation, Stryker Corporation, Edwards Lifesciences Corporation, and Cardinal Health. Strategies focus on developing innovative CABG technologies, integrating AI and predictive analytics, and forming strategic partnerships to expand market reach.

Read more: Coronary Artery Bypass Graft Market Research Report

People Also Ask

Q1. What is coronary artery bypass graft surgery and why is it important?
Coronary artery bypass graft (CABG) surgery is a life-saving procedure that restores blood flow to the heart by bypassing blocked coronary arteries using grafts, treating coronary artery disease, myocardial ischemia, and other cardiovascular conditions.

Q2. Which region leads the coronary artery bypass graft market?
North America leads due to advanced healthcare infrastructure and increasing prevalence of cardiovascular diseases, while Asia-Pacific is emerging rapidly, driven by rising disposable incomes and improvements in healthcare infrastructure.

Tags: coronary artery bypass graft, CABG surgery, cardiovascular disease, robotic-assisted surgery, saphenous vein graft, internal mammary artery graft